145 related articles for article (PubMed ID: 11555673)
1. Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate.
Zeigler M; Chi Y; Tumas DB; Bodary S; Tang H; Varani J
Lab Invest; 2001 Sep; 81(9):1253-61. PubMed ID: 11555673
[TBL] [Abstract][Full Text] [Related]
2. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
3. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
4. Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments.
Lebwohl M; Lombardi K; Tan MH
Int J Dermatol; 2001 Jan; 40(1):64-6. PubMed ID: 11277960
[No Abstract] [Full Text] [Related]
5. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
[TBL] [Abstract][Full Text] [Related]
6. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
7. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
8. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
[TBL] [Abstract][Full Text] [Related]
9. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.
Gottlieb A; Krueger JG; Bright R; Ling M; Lebwohl M; Kang S; Feldman S; Spellman M; Wittkowski K; Ochs HD; Jardieu P; Bauer R; White M; Dedrick R; Garovoy M
J Am Acad Dermatol; 2000 Mar; 42(3):428-35. PubMed ID: 10688712
[TBL] [Abstract][Full Text] [Related]
10. Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice.
Bhagavathula N; Nerusu KC; Fisher GJ; Liu G; Thakur AB; Gemmell L; Kumar S; Xu ZH; Hinton P; Tsurushita N; Landolfi NF; Voorhees JJ; Varani J
Am J Pathol; 2005 Apr; 166(4):1009-16. PubMed ID: 15793282
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
Gottlieb AB; Ford RO; Spellman MC
J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
[TBL] [Abstract][Full Text] [Related]
12. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice.
Gilhar A; David M; Ullmann Y; Berkutski T; Kalish RS
J Invest Dermatol; 1997 Sep; 109(3):283-8. PubMed ID: 9284091
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment.
Talme T; Schultzberg M; Sundqvist KG; Marcusson JA
Acta Derm Venereol; 1999 Jan; 79(1):44-8. PubMed ID: 10086858
[TBL] [Abstract][Full Text] [Related]
14. Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
van der Vleuten CJ; Snijders CG; de Jong EM; van de Kerkhof PC
Skin Pharmacol; 1996; 9(6):355-65. PubMed ID: 9055356
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
Angelo JS; Kar BR; Thomas J
Indian J Dermatol Venereol Leprol; 2007; 73(1):65. PubMed ID: 17319037
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot study.
Lacarrubba F; Nardone B; Musumeci ML; Micali G
Dermatol Ther; 2009 Nov; 22 Suppl 1():S19-21. PubMed ID: 19891687
[TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
[TBL] [Abstract][Full Text] [Related]
18. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
[TBL] [Abstract][Full Text] [Related]
19. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Mommers JM; van Erp PE; van De Kerkhof PC
Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
